Couverture de Pertussis: EXPOSED

Pertussis: EXPOSED

Pertussis: EXPOSED

De : Sanofi
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Pertussis: EXPOSED is developed and funded by Sanofi, and these podcasts are intended for a healthcare professional audience.

Pertussis is generally considered to be an infection of childhood – but are adults at risk too?

Listen to the “Pertussis: EXPOSED ” podcast series, where world-renowned experts are exploring the global health concern of pertussis infection across all age groups. In the first two episodes, experts will delve into the unanswered questions surrounding pertussis infection in all adult populations, including adults with chronic medical conditions.

Episode 1. Exploring pertussis infection in all adults (MAT-GLB-2305969)
Episode 2. The nuances of pertussis infection in adults with chronic medical conditions (MAT-GLB-2305971)

Expert guests
Dr John Blakey, Sir Charles Gairdner Hospital, Curtin University, Australia
Dr Scott Halperin, Dalhousie University, IWK Health Centre, Canada
Tanya Heeraman-Ray, Patient testimonial, Australia
Prof. Ulrich Heininger, The University Children’s Hospital Basel, Switzerland
Dr Daphne Holt, Coalition for Life-Course Immunisation, France
Dr Donald Middleton, University of Pittsburgh School of Medicine, United States
Prof. Alberto Papi, University of Ferrara, Italy
Elizabeth Sobczyk, The Society for Post-Acute and Long-Term Care Medicine, United States
Prof. Carl Heinz Wirsing von König, University of Düsseldorf, Germany

Host
Dr Liana Clark, Vaccine Expert, Sanofi, United States

Uncover the complexities and uncertainties surrounding pertussis infection in adults.

© 2024 Pertussis: EXPOSED
Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Episode 2: The nuances of pertussis infection in adults with chronic medical conditions
      Mar 1 2024

      Send us a text

      Certain adult populations are at increased risk of severe disease from pertussis; however, which adults are more susceptible to severe pertussis disease, and how does pertussis affect these adults?

      Host, Liana Clark, meets with leading experts in the field to explore the affect of pertussis on adults with existing chronic medical conditions and strategies for prevention through vaccination.

      Pertussis: EXPOSED is developed and funded by Sanofi, and these podcasts are intended for a healthcare professional audience.

      Expert guests:

      Dr John Blakey, Sir Charles Gairdner Hospital, Curtin University, Australia

      Tanya Heeraman-Ray, Patient, Australia

      Dr Donald Middleton, University of Pittsburgh School of Medicine, United States

      Prof. Alberto Papi, University of Ferrara, Italy

      Elizabeth Sobczyk, The Society for Post-Acute and Long-Term Care Medicine, United States

      Prof. Carl Heinz Wirsing von König, University of Düsseldorf, Germany

      Afficher plus Afficher moins
      19 min
    • Episode 1: Exploring pertussis infection in all adults
      Mar 1 2024

      Send us a text


      Pertussis is a highly contagious bacterial infection that is widely considered to be a disease of childhood – but what is the impact of pertussis in the adult population?

      Host, Liana Clark, meets with leading experts in the field to delve deeper into the impact of pertussis infection in adults and explore how vaccination can protect them against this disease.

      Pertussis: EXPOSED is developed and funded by Sanofi, and these podcasts are intended for a healthcare professional audience.

      Expert guests:

      Dr Scott Halperin, Dalhousie University, IWK Health Centre, Canada

      Tanya Heeraman-Ray, Patient, Australia

      Prof. Ulrich Heininger, The University Children’s Hospital Basel, Switzerland

      Dr Daphne Holt, Coalition for Life-Course Immunisation, France

      Dr Donald Middleton, University of Pittsburgh School of Medicine, United States

      Elizabeth Sobczyk, The Society for Post-Acute and Long-Term Care Medicine, United States

      Prof. Carl Heinz Wirsing von König, University of Düsseldorf, Germany

      Afficher plus Afficher moins
      24 min
    Aucun commentaire pour le moment